Literature DB >> 24217459

Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI.

Dimitri P Mikhailidis1, Vasilios G Athyros2.   

Abstract

Two recent studies suggest that periprocedural statin administration can prevent contrast-induced acute kidney injury in cardiac patients undergoing percutaneous coronary intervention and in renal patients undergoing angiography, with or without intervention. These studies support the routine administration of potent statins before contrast media infusion in these vulnerable patients.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24217459     DOI： 10.1038/nrneph.2013.249

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

1.  Epidemiology and prognostic implications of contrast-induced nephropathy.

Authors:  Peter A McCullough; Andy Adam; Christoph R Becker; Charles Davidson; Norbert Lameire; Fulvio Stacul; James Tumlin
Journal:  Am J Cardiol       Date:  2006-02-10       Impact factor: 2.778

2.  Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity.

Authors:  Vasilios G Athyros; Asterios Karagiannis; Niki Katsiki; Dimitri P Mikhailidis
Journal:  Am J Cardiol       Date:  2012-09-01       Impact factor: 2.778

3.  Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury.

Authors:  Cristina Quintavalle; Danilo Fiore; Francesca De Micco; Gabriella Visconti; Amelia Focaccio; Bruno Golia; Bruno Ricciardelli; Elvira Donnarumma; Antonio Bianco; Maria Assunta Zabatta; Giancarlo Troncone; Antonio Colombo; Carlo Briguori; Gerolama Condorelli
Journal:  Circulation       Date:  2012-11-12       Impact factor: 29.690

4.  Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).

Authors:  Mario Leoncini; Anna Toso; Mauro Maioli; Francesco Tropeano; Simona Villani; Francesco Bellandi
Journal:  J Am Coll Cardiol       Date:  2013-09-26       Impact factor: 24.094

5.  Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.

Authors:  Yaling Han; Guoying Zhu; Lixian Han; Fengxia Hou; Weijian Huang; Huiliang Liu; Jihong Gan; Tiemin Jiang; Xiaoyan Li; Wei Wang; Shifang Ding; Shaobin Jia; Weifeng Shen; Dongmei Wang; Ling Sun; Jian Qiu; Xiaozeng Wang; Yi Li; Jie Deng; Jing Li; Kai Xu; Bo Xu; Roxana Mehran; Yong Huo
Journal:  J Am Coll Cardiol       Date:  2013-09-26       Impact factor: 24.094

6.  Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study).

Authors:  Jennifer E Ho; David D Waters; Allison Kean; Daniel J Wilson; David A Demicco; Andrei Breazna; Chuan-Chuan Wun; Prakash C Deedwania; Kiran K Khush
Journal:  Am J Cardiol       Date:  2012-03-28       Impact factor: 2.778

7.  Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.

Authors:  Giuseppe Patti; Elisabetta Ricottini; Annunziata Nusca; Giuseppe Colonna; Vincenzo Pasceri; Andrea D'Ambrosio; Antonio Montinaro; Germano Di Sciascio
Journal:  Am J Cardiol       Date:  2011-04-27       Impact factor: 2.778

Review 8.  Current concepts of contrast-induced nephropathy: a brief review.

Authors:  Chao-Fu Chang; Chih-Ching Lin
Journal:  J Chin Med Assoc       Date:  2013-10-03       Impact factor: 2.743

9.  Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

Authors:  Vincenzo Pasceri; Giuseppe Patti; Annunziata Nusca; Christian Pristipino; Giuseppe Richichi; Germano Di Sciascio
Journal:  Circulation       Date:  2004-07-26       Impact factor: 29.690

Review 10.  Contrast-induced acute kidney injury.

Authors:  Peter A McCullough
Journal:  J Am Coll Cardiol       Date:  2008-04-15       Impact factor: 24.094
  10 in total
  1 in total

Review 1.  Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?

Authors:  Andromachi Reklou; Michael Doumas; Konstantinos Imprialos; Konstantinos Stavropoulos; Dimitris Patoulias; Vasilios G Athyros
Journal:  Open Cardiovasc Med J       Date:  2018-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.